| (4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol;sulfuric acid;pentahydrate |
| (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol, hydrogen sulfate (2:1) |
| 1095-53-0 |
| 17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6-diol sulfate (2:1) |
| 17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6-diol sulfate (2:1) pentahydrate |
| 178935-96-1 |
| 4,5-alpha-Epoxy-17-methylmorphinan-3,5-alpha-diol sulfate hydrate (2:1:5) |
| 57-27-2 (Parent) |
| 6211-15-0 |
| 64-31-3 |
| 66591-53-5 |
| 7,8-Didehydro-4,5alpha-epoxy-17-methylmorphinan-3,6alpha-diol sulfate (2:1) (salt) pentahydrate |
| 92004-19-8 |
| Apomorphine impurity B (morphine sulfate), European Pharmacopoeia (EP) Reference Standard |
| Arymo ER |
| Astramor PH (TN) |
| Astramorph |
| Astramorph PF |
| Avinza |
| Avinza (TN) |
| CAS-6211-15-0 |
| CHEBI:50731 |
| CHEBI:7003 |
| CHEMBL2096625 |
| CHEMBL2103744 |
| D00842 |
| Depodur (TN) |
| Di(morphine) dihydrogen sulfate pentahydrate |
| DSSTox_CID_28840 |
| DSSTox_GSID_48914 |
| DSSTox_RID_83109 |
| DTXSID1048914 |
| DTXSID4023830 |
| Duramorph |
| Duramorph PF |
| DY70C97N30 |
| EINECS 200-582-8 |
| Kadian (TN) |
| Kapanol |
| l-Morphine sulfate |
| Morphabond |
| Morphinan-3,6-alpha-diol, 7,8-didehydro-4, 5-alpha-epoxy-17-methyl-, sulfate |
| Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, sulfate (2:1) (salt) |
| Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-(5-alpha,6-alpha)-, sulfate (2:1) (salt), pentahdrate |
| Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl, (5alpha,6alpha)-, sulfate (2:1) (salt), pentahydrate |
| Morphinan-3,6alpha-diol, 7,8-didehydro-4,5alpha-epoxy-17-methyl-, sulfate (2:1) (salt) |
| Morphinan-3,6alpha-diol, 7,8-didehydro-4,5lpha-epoxy-17-methyl-, sulfate (2:1) (salt), pentahydrate |
| Morphine Extra-Forte |
| Morphine for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Morphine Forte |
| Morphine H.P |
| Morphine hemi[sulfate pentahydrate] |
| Morphine Hemisulfate Pentahemihydrate |
| Morphine Hemisulphate Pentahemihydrate |
| Morphine sulfat, European Pharmacopoeia (EP) Reference Standard |
| MORPHINE SULFATE |
| Morphine Sulfate (anhydrous) |
| Morphine sulfate (USP) |
| Morphine sulfate [USP:JAN] |
| Morphine sulfate hydrate |
| Morphine sulfate hydrate (JP17) |
| MORPHINE SULFATE NARCOTIC ANALGESIC |
| Morphine sulfate pentahydrate |
| Morphine sulfate salt pentahydrate |
| Morphine sulfate salt pentahydrate, analytical standard |
| Morphine sulfate salt solution |
| Morphine sulfate salt solution, 1.0 mg/mL in methanol, drug standard |
| morphine sulfate--dea schedule ii item |
| Morphine sulfate, United States Pharmacopeia (USP) Reference Standard |
| Morphine sulphate |
| Morphine sulphate (2:1) |
| Morphine sulphate pentahydrate |
| Morphine, hemisulfate |
| MORPHINIUMCHLORIDE |
| MS contin (TN) |
| MST-1 Continus |
| NCGC00247707-01 |
| NIH 0001 |
| NIH 10753 |
| NSC 11441 |
| Oramorph SR |
| SCHEMBL29316 |
| Skenan |
| Tox21_112861 |
| UNII-DY70C97N30 |
| UNII-X3P646A2J0 |
| X3P646A2J0 |
